KARI ROARK VERGNE: Open Payments
NPI 1669157574 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 68 payments from 10 companies in 2025. Trend: 2023 $139 · 2024 $566 · 2025 $1,125
Food & beverage: $1,123Education: $2
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 18 | $329 |
| Shionogi Inc | 23 | $291 |
| Merck Sharp & Dohme LLC | 8 | $141 |
| Melinta Therapeutics, LLC | 5 | $112 |
| Aimmune Therapeutics, Inc. | 6 | $106 |
| Insmed, Inc. | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| CeQur Corporation | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $15 |
Products named: NUZYRA, Fetroja, ZERBAXA, Rezzayo, VOWST, Arikayce, GVOKE HYPOPEN, CeQur Simplicity.
Industry payments across KY — which companies pay providers there.
